Oligonucleotides are giving rise to a new generation of therapeutics — and Nitto Avecia is leading the way. With more than 30 years’ experience in oligonucleotide development and production, we are the partner of choice for pharmaceutical innovators creating new drugs with the power to transform treatment for a wide range of diseases.
Oligonucleotides are giving rise to a new generation of therapeutics — and Nitto Avecia is leading the way. With more than 30 years’ experience in oligonucleotide development and production, we are the partner of choice for pharmaceutical innovators creating new drugs with the power to transform treatment for a wide range of diseases.
Preclinical Manufacturing >
Our OliGrow® service provides a complete solution for custom, preclinical manufacturing.
Analytical Development >
We develop, qualify, and validate analytical methods for raw materials, intermediates, and final product.
Process Development >
Our experts develop and validate a safe, robust, cost-effective process to advance your oligonucleotide program.
Drug Substance
Manufacturing >
We provide a complete solution for oligonucleotide manufacturing, tapping our 25+ years of experience.
Process Performance
Optimization >
We develop and execute a comprehensive PPQ Program.
Quality Control /
Stability >
We provide expert study design, comprehensive testing services, and a variety of sample storage conditions.
Nitto Avecia was the first CDMO to serve the oligonucleotide therapeutic market. Since then, we have manufactured more than 1,200 oligonucleotide sequences and developed the most extensive late-phase portfolio of any oligonucleotide CDMO. This experience gives our analytical, manufacturing, and quality teams unparalleled expertise to make your oligonucleotide program a success.
In partnership with Nitto Avecia Pharma Services, Nitto Avecia offers customers a seamless experience across oligonucleotide development. By integrating drug substance development and manufacturing with analytical testing services, our teams work together to provide efficient project execution, scientific expertise, and dependable quality from development through commercialization.
Our FDA-inspected, GMP-compliant facilities in Massachusetts and Ohio are optimized to meet the specialized needs of the oligonucleotide market, from pre-clinical through commercial production. We continually expand and update our technical capabilities to meet our customers’ evolving needs.
At Nitto Avecia, we relentlessly pursue products, processes, and technologies that create value for our customers. As part of Nitto Group, we share a common vision: “Creating Wonders.” Each of us, every day, works to create wonders with the power to change the world.
125 Fortune Boulevard
Milford, MA 01757
Tel: (508) 532-2500
8560 Reading Road
Cincinnati, OH 45215
Tel: (513) 679-3000
